China’s healthcare sector has been drawing offshore capital to Hong Kong-listed stocks as investors look for safe havens amid global volatility in commodities.
The Hang Seng Healthcare Index, tracking some of China’s most innovative pharmaceutical companies including Akeso and Innovent Biologics, has surged about 13 per cent since March 23, outpacing the benchmark Hang Seng Index’s about 6 per cent gain over the same period.
“Although the Middle East conflict has created a lot of uncertainty and…
China healthcare stocks outgain Hong Kong market as Middle East roils global investments
